Q3 FY24-Thyrocare reports net profit of Rs 14.74 crore

Thyrocare Technologies consolidated net profit remained flat at Rs 14.74 crore in Q3 FY24 . The company had reported a profit of Rs 14.70 crore in the same period, Q2 FY24.

Revenue came in at Rs 134.7 crore, up 5.2 percent from the year-ago quarter. EBITDA stood at Rs 34.3 crore, up from Rs 32.3 crore in the year-ago period.

The normalised EBITDA margin came at 26 percent against 27 percent last year. The decline was mainly on account of an increase in marketing spends.

Highlights:

• Partnerships (excluding API & B2G) revenue growth of 33% Y-o-Y
• Franchise revenue growth of 11% Y-o-Y
• Pathology (excluding materials & others) revenue grew by 8% Y-o-Y
• Radiology revenue grew by 9% Y-o-Y
• Execution of share purchase agreement for acquisition of 100% stake in Think Health Diagnostic Private Limited to foray into ECG at home services
• Entered into partnership with TestEasy to introduce genome sequencing

MB Bureau